Cyclodextrin inclusion complexes enhance the solubility and anti-virulence activity of metronidazole against uropathogenic Proteus mirabilis
Rehab Mahmoud Abd El-Baky, Zeinab Fathalla, Hala Rady Ahmed, Ramadan Yahia, Mohamed A Mawhoup, Ghada M Sadiq, Hebatallah S Barakat, Adel Al Fatease · 2026
Read Cyclodextrin inclusion complexes enhance the solubility and anti-virulence activity of metronidazole against uropathogenic Proteus mirabilis by Rehab Mahmoud Abd El-Baky, Zeinab Fathalla, Hala Rady Ahmed, Ramadan Yahia, Mohamed A Mawhoup, Ghada M Sadiq, Hebatallah S Barakat, Adel Al Fatease (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0353058.txt.
Description
Abd El-Baky and colleagues, in a 2026 study, try to make an old drug, metronidazole, work better against a germ that infects the urinary tract. The germ, Proteus mirabilis, often strikes people with catheters and can help form stones. It also resists many drugs. The team's idea is to tuck the drug inside ring-shaped sugar carriers called cyclodextrins.
Three kinds of carrier were mixed with the drug by simple blending or kneading. Lab tests checked how the pairs formed and how fast the drug was released. Two carriers improved release, and one pairing needed a much lower dose to slow the germ. At doses too low to kill, the paired drug still cut the germ's swimming, its stone-linked enzyme action, and its ability to build biofilms, the slimy layers that shield germs. The authors say animal studies must come next before any clinical use.
Catalog record
| CREATOR | Rehab Mahmoud Abd El-Baky, Zeinab Fathalla, Hala Rady Ahmed, Ramadan Yahia, Mohamed A Mawhoup, Ghada M Sadiq, Hebatallah S Barakat, Adel Al Fatease |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50294 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |